We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Puerto Rican Facility Cited for Manufacturing and Quality Issues
Puerto Rican Facility Cited for Manufacturing and Quality Issues
An Eli Lilly facility in Puerto Rico drew the FDA’s attention for manufacturing and quality deficiencies related to its breast cancer treatment abemaciclib.